These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2659619)

  • 1. The effect of near-normoglycemic control on plasma factor VIII/von Willebrand factor and fibrin degradation products in insulin-dependent diabetic patients.
    Vukovich TC; Schernthaner G; Knöbi PN; Hay U
    J Clin Endocrinol Metab; 1989 Jul; 69(1):84-9. PubMed ID: 2659619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolytic system during long-distance running in IDDM patients and in healthy subjects.
    van Loon BJ; Heere LP; Kluft C; Briët E; Dooijewaard G; Meinders AE
    Diabetes Care; 1992 Aug; 15(8):991-6. PubMed ID: 1505332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. von Willebrand factor and development of diabetic nephropathy in IDDM.
    Stehouwer CD; Stroes ES; Hackeng WH; Mulder PG; Den Ottolander GJ
    Diabetes; 1991 Aug; 40(8):971-6. PubMed ID: 1907250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand factor antigen in plasma and urine in patients with type I (insulin-dependent) diabetes mellitus with and without nephropathy.
    Silveira AM; Sjöberg S; Blombäck M; Ostman J
    J Diabetes Complications; 1992; 6(2):89-95. PubMed ID: 1611144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UK Prospective Diabetes Study (UKPDS). XI: Biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects.
    Diabet Med; 1994 Jul; 11(6):534-44. PubMed ID: 7955969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor.
    Bovill EG; Ershler WB; Golden EA; Tindle BH; Edson JR
    Am J Clin Pathol; 1986 Jan; 85(1):115-23. PubMed ID: 3079626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of near-normoglycaemic control on plasma levels of coagulation factor VII and the anticoagulant proteins C and S in insulin-dependent diabetic patients.
    Schernthaner G; Vukovich T; Knöbl P; Hay U; Müller MM
    Br J Haematol; 1989 Nov; 73(3):356-9. PubMed ID: 2532536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between high von willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes. The GENEDIAB Study Group and the DESIR Study Group.
    Lacquemant C; Gaucher C; Delorme C; Chatellier G; Gallois Y; Rodier M; Passa P; Balkau B; Mazurier C; Marre M; Froguel P
    Kidney Int; 2000 Apr; 57(4):1437-43. PubMed ID: 10760079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated von Willebrand factor antigen predicts deterioration in diabetic peripheral nerve function.
    Plater ME; Ford I; Dent MT; Preston FE; Ward JD
    Diabetologia; 1996 Mar; 39(3):336-43. PubMed ID: 8721780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness of fructosamine determination in short-term monitoring of metabolic control in children with insulin-dependent diabetes mellitus at onset].
    De Campo C; Monciotti C; Grossi F; Bertotti A; Pocecco M
    Pediatr Med Chir; 1987; 9(5):583-4. PubMed ID: 3327054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of a bleeding tendency in severe acquired von Willebrand's disease. The role of platelet von Willebrand factor in maintaining normal hemostasis.
    Drouin J; Lillicrap DP; Izaguirre CA; Sutherland M; Windsor S; Benford K; Hoogendorn H; Giles AR
    Am J Clin Pathol; 1989 Oct; 92(4):471-8. PubMed ID: 2508465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum fatty acids profile of uncontrolled insulin dependent diabetic patients and the effect of improved metabolic control.
    Gomo Z; Cmelik SH; Taylor GO
    Cent Afr J Med; 1993 Dec; 39(12):258-62. PubMed ID: 8055559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. von Willebrand factor and early diabetic retinopathy: no evidence for a relationship in patients with type 1 (insulin-dependent) diabetes mellitus and normal urinary albumin excretion.
    Stehouwer CD; Zellenrath P; Polak BC; Baarsma GS; Nauta JJ; Donker AJ; den Ottolander GJ
    Diabetologia; 1992 Jun; 35(6):555-9. PubMed ID: 1612229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fructosamine assay: an index of medium-term metabolic control parameters in diabetic disease.
    Lapolla A; Poli T; Barison A; Fedele D
    Diabetes Res Clin Pract; 1988 Feb; 4(3):231-5. PubMed ID: 3359924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-four hour variations of von Willebrand factor and factor VIII-related antigen in diabetic retinopathy.
    Porta M; Maneschi F; White MC; Kohner EM
    Metabolism; 1981 Jul; 30(7):695-9. PubMed ID: 6787387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P).
    Michiels JJ; Berneman ZN; van der Planken M; Schroyens W; Budde U; van Vliet HH
    Blood Coagul Fibrinolysis; 2004 Jun; 15(4):323-30. PubMed ID: 15166918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of coagulation in diabetes mellitus in relation to the presence of vascular complications.
    Ford I; Singh TP; Kitchen S; Makris M; Ward JD; Preston FE
    Diabet Med; 1991 May; 8(4):322-9. PubMed ID: 1830255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemostatic measures in type 2 diabetic patients with microalbuminuria.
    Schmitz A; Ingerslev J
    Diabet Med; 1990 Jul; 7(6):521-5. PubMed ID: 2142055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen and markers of fibrinolysis and endothelial damage following resolution of critical limb ischaemia.
    Woodburn KR; Rumley A; Lowe GD; Pollock JG
    Eur J Vasc Endovasc Surg; 1995 Oct; 10(3):272-8. PubMed ID: 7552524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marked von Willebrand factor and factor VIII elevations in severe acute respiratory syndrome coronavirus-2-positive, but not severe acute respiratory syndrome coronavirus-2-negative, pneumonia: a case-control study.
    De Cristofaro R; Liuzzo G; Sacco M; Lancellotti S; Pedicino D; Andreotti F
    Blood Coagul Fibrinolysis; 2021 Jun; 32(4):285-289. PubMed ID: 33443926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.